- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Høyrisiko ulmende myelomatose in United States
Totalt 2366 resultater
-
Irene Ghobrial, MDJanssen Research & Development, LLCRekrutteringMultippelt myelom | Ulmende myelomatose | Høyrisiko ulmende myelomatoseForente stater
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.AvsluttetHøyrisiko ulmende myelomatoseForente stater
-
Omar Nadeem, MDJanssen, LPRekruttering
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.FullførtMultippelt myelom | Høyrisiko ulmende myelomatoseForente stater
-
Janssen Research & Development, LLCFullførtHøyrisiko ulmende myelomatoseForente stater, Storbritannia, Belgia, Tyskland, Frankrike, Spania, Korea, Republikken, Australia, Israel, Hellas, Sverige
-
National Cancer Institute (NCI)AvsluttetMyelom, multippel | Myelom-multippelForente stater
-
Michael A. Thompson, MD, PhDVince Lombardi Cancer ClinicFullførtMultippelt myelom | Myelom, multippel | Myelom-multippelForente stater
-
US Oncology ResearchKaryopharm Therapeutics IncRekrutteringMultippelt myelom | Plasmacellemyelom | Myelom-multippel | Myelom multippel | Kahlers sykdom | Myelom, plasmacelle | MyelomatoseForente stater
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncAvsluttetRefraktært myelomatose | Myelom | Myelom multippelForente stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
University College, LondonCancer Research UKRekrutteringMultippelt myelom | MGUS | Ulmende myelomStorbritannia
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthAvsluttetMyelom-multippel | Myelom, plasmacelle | MyelomatoseForente stater
-
Novartis PharmaceuticalsFullførtRefraktært myelomatose | Myelomatose i tilbakefall | Tilbakefall og Bortezomib Refractory Multiple MyelomaForente stater
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RekrutteringPlasmacellemyelom | RISS stadium I Plasmacellemyelom | RISS stadium II plasmacellemyelomForente stater
-
Cartesian TherapeuticsRekrutteringMyelom multippelForente stater
-
Benovus Bio, Inc.UkjentMyelodysplastisk syndrom (MDS) | Akutt myelogen leukemi (AML) | Myelomatose (MM) | Ulmende myelomatose (sMM)Forente stater
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringUlmende plasmacellemyelomForente stater
-
M.D. Anderson Cancer CenterAktiv, ikke rekrutterendeUlmende plasmacellemyelomForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)TilbaketrukketUlmende plasmacellemyelomForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterende
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeUlmende plasmacellemyelomForente stater
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRekrutteringNavlestrengsblodtransplantasjon | Myeloid malignitet med høy risikoForente stater
-
Cartesian TherapeuticsFullførtMyelom multippelForente stater
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRekrutteringMultippelt myelomForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeUlmende plasmacellemyelomForente stater
-
University of Colorado, DenverAvsluttetPlasmacellemyelom | Tilbakevendende plasmacellemyelom | Ulmende plasmacellemyelom | PlasmacytoseForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringUlmende plasmacellemyelomForente stater
-
University of UtahMillennium Pharmaceuticals, Inc.AvsluttetKreft | Multippelt myelom | MyelomForente stater
-
Memorial Sloan Kettering Cancer CenterHealthTree FoundationRekrutteringMyelomatose, ulmingForente stater
-
Case Comprehensive Cancer CenterTilbaketrukketMyelom | Ulmende myelom | Monoklonal gammopatiForente stater
-
National Cancer Institute (NCI)AvsluttetMonoklonal gammopati av ubestemt betydning | Ulmende myelomForente stater
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple... og andre samarbeidspartnereFullførtE-PRISM: Fase II-studie av Elotuzumab Lenalidomide og Deksametason ved høyrisiko ulmende myelomatoseUlmende myelomatose | Ulmende myelomForente stater
-
Mayo ClinicNational Cancer Institute (NCI)FullførtPlasmacellemyelom | Ulmende plasmacellemyelom | Indolent plasmacellemyelomForente stater
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKTilbaketrukketPembrolizumab cyklofosfamid og lenalidomid for pasienter med residiverende myelomatose (MUKfourteen)Myelom multippelStorbritannia
-
K36 Therapeutics, Inc.RekrutteringMultippelt myelom | Myelom | Myelom multippelForente stater, Frankrike, Spania, Canada
-
Mayo ClinicAktiv, ikke rekrutterendePlasmacellemyelom | Refraktært plasmacellemyelom | Tilbakevendende plasmacellemyelom | Ulmende plasmacellemyelomForente stater
-
City of Hope Medical CenterFullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Ulmende myelomatose | Refraktært myelomatoseForente stater
-
Novartis PharmaceuticalsFullførtMultippel myelom beinsykdomStorbritannia, Forente stater
-
Oxford University Hospitals NHS TrustAmgenFullførtMyelom | Ulmende myelom | Monoklonal gammopati av ubestemt betydning (MGUS)Storbritannia
-
M.D. Anderson Cancer CenterRekruttering
-
Roswell Park Cancer InstituteRekrutteringPlasmacellemyelom | Refraktært plasmacellemyelom | Tilbakevendende plasmacellemyelom | Ulmende plasmacellemyelomForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringMonoklonal gammopati av ubestemt betydning | Ulmende plasmacellemyelomForente stater
-
Abramson Cancer Center at Penn MedicineRekruttering
-
UNC Lineberger Comprehensive Cancer CenterConquer Cancer FoundationFullførtMultippelt myelom | Myelom | Funksjonshemming Fysisk | Funksjonshemminger MultipleForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringMonoklonal gammopati av ubestemt betydning | Ulmende plasmacellemyelomForente stater
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RekrutteringUlmende plasmacellemyelomForente stater
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationAktiv, ikke rekrutterende
-
New York City Health and Hospitals CorporationNew York State Department of HealthFullførtHøyrisiko- og høykostnadsbrukere av Medicaid-tjenesterForente stater